JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 2, 2005; DOI: 10.1124/jpet.104.082990


0022-3565/05/3133-1066-1074$20.00
JPET 313:1066-1074, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.082990v1
313/3/1066    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kinarsky, L.
Right arrow Articles by Monaghan, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinarsky, L.
Right arrow Articles by Monaghan, D. T.

NEUROPHARMACOLOGY

Identification of Subunit- and Antagonist-Specific Amino Acid Residues in the N-Methyl-D-aspartate Receptor Glutamate-Binding Pocket

Leo Kinarsky1, Bihua Feng1, Donald A. Skifter, Richard M. Morley, Simon Sherman, David E. Jane, and Daniel T. Monaghan

The Eppley Research Institute (L.K., S.S.) and the Department of Pharmacology (B.F., D.A.S., D.T.M.), University of Nebraska Medical Center, Omaha, Nebraska; and Department of Pharmacology, University of Bristol, Bristol, United Kingdom (R.M.M., D.E.J.)

The resolved X-ray crystal structures of the glutamate-binding domain (S1/S2 domains) of the GluR2 and NR1 glutamate receptor subunits were used to model the homologous regions of the N-methyl-D-aspartate (NMDA) receptor's NR2 subunits. To test the predictive value of these models, all four stereoisomers of the antagonist 1-(phenanthren-2-carbonyl) piperazine-2,3-dicarboxylic acid (PPDA) were docked into the NR2B glutamate-binding site model. This analysis suggested an affinity order for the PPDA isomers of D-cis > L-cis > L-trans = D-trans and predicted that the 2-position carboxylate group of the cis-PPDA isomers, but not of the trans-PPDA isomers, may be interacting with histidine 486 in NR2B. Consistent with these predictions, cis-PPDA displays a 35-fold higher affinity for NR2B-containing NMDA receptors than trans-PPDA. In addition, mutating NR2B's H486 to phenylalanine decreased cis-PPDA affinity 8-fold but had no effect on trans-PPDA affinity. In contrast, the NR2B H486F mutation increased the affinity of the typical antagonists CGS-19755 [(2R*,4S*)-4-phosphonomethyl-2-piperidine carboxylic acid] and 4-(3-phosphonopropyl) piperidine-2-carboxylic acid. In the NR1-based NR2 models, there were only four subunit-specific amino acid residues exposed to the ligand-binding pocket (and six in the GluR2-based models). These residues are located at the edge of the binding pocket, suggesting that large antagonists may be necessary for subtype specificity. Of these residues, mutational analysis and modeling suggest that A414, R712, and G713 (NR2B numbering) may be especially useful for developing NR2C- and NR2D-selective NMDA receptor antagonists and that residues A414 and T428 may determine subunit variations in agonist affinity.


Received for publication December 29, 2004
Accepted February 25, 2005.

Address correspondence to: Dr. Daniel T. Monaghan, Department of Pharmacology, 985800 Nebraska Medical Center, Omaha, NE 68198-5800. E-mail: dtmonagh{at}unmc.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
B. M. Costa, B. Feng, T. S. Tsintsadze, R. M. Morley, M. W. Irvine, V. Tsintsadze, N. A. Lozovaya, D. E. Jane, and D. T. Monaghan
N-Methyl-D-aspartate (NMDA) Receptor NR2 Subunit Selectivity of a Series of Novel Piperazine-2,3-dicarboxylate Derivatives: Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA3-CA1 Synapse
J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 618 - 626.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. E. Chen, M. T. Geballe, E. Katz, K. Erreger, M. R. Livesey, K. K. O'Toole, P. Le, C. J. Lee, J. P. Snyder, S. F. Traynelis, et al.
Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes
J. Physiol., January 1, 2008; 586(1): 227 - 245.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
C. Villmann and C.-M. Becker
On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor
Neuroscientist, December 1, 2007; 13(6): 594 - 615.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
P. T. Atlason, M. L. Garside, E. Meddows, P. Whiting, and R. A. J. McIlhinney
N-Methyl-D-aspartate (NMDA) Receptor Subunit NR1 Forms the Substrate for Oligomeric Assembly of the NMDA Receptor
J. Biol. Chem., August 31, 2007; 282(35): 25299 - 25307.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. L. Hammond, C. Sims, K. Parameshwaran, V. Suppiramaniam, M. Schachner, and A. Dityatev
Neural Cell Adhesion Molecule-associated Polysialic Acid Inhibits NR2B-containing N-Methyl-D-aspartate Receptors and Prevents Glutamate-induced Cell Death
J. Biol. Chem., November 17, 2006; 281(46): 34859 - 34869.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. B. Hansen, R. P. Clausen, E. J. Bjerrum, C. Bechmann, J. R. Greenwood, C. Christensen, J. L. Kristensen, J. Egebjerg, and H. Brauner-Osborne
Tweaking Agonist Efficacy at N-Methyl-D-aspartate Receptors by Site-Directed Mutagenesis
Mol. Pharmacol., December 1, 2005; 68(6): 1510 - 1523.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.